Edwards Lifesciences Corp. (EW) Posts Mixed Q4 Results
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $88.78 --0%
Revenue Growth %: +8.4%
Financial Fact:
Cost of goods sold: 201.4M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +8.4%
Financial Fact:
Cost of goods sold: 201.4M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $430.2 million versus the consensus estimate of $446.94 million.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
For earnings history and earnings-related data on Edwards Lifesciences Corp. (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
- UBS Upgrades Bajaj Finance Ltd. (BAF:IN) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
